Drugs / SclerFIX
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05236049 | Jul 2019 → Apr 2022 | ocular cancer | TBF Genie Tissulaire | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05302609 | Jul 2022 → Feb 2024 | scleral disorder | TBF Genie Tissulaire | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SclerFIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05302609 ↗ |
| Modality | Other / unclassified | “an allograft of umbilical cord lining membrane” NCT05236049 ↗ |
| Route | Other | “The assembly is placed inside the void orbital cavity” NCT05236049 ↗ |